Related content

BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis

By Mao Chen   Liao Ru-Yan   Qiu Li-Xin   Wang Xi-Wen   Ding Hong   Chen Qing  

Molecular Biology Reports, Vol. 38, Iss. 4, 2011-04 ,pp. : 2219-2223

Springer Publishing Company

Access to resources Recommend Favorite

The developing trend of monoclonal antibodies in the treatment of colorectal cancer

By Elfiky Aymen A   Saif Muhammad W  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 871-883

Informa Healthcare

Access to resources Recommend Favorite

Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies

By Liu Li  

Molecular Biology Reports, Vol. 40, Iss. 6, 2013-06 ,pp. : 3943-3952

Springer Publishing Company

Access to resources Recommend Favorite

The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 casecontrol studies

By Chen Zhiwei   Li Ziming   Niu Xiaomin   Ye Xiangyun   Yu Yongfeng   Lu Shun   Chen Zhen  

Mutagenesis, Vol. 26, Iss. 3, 2011-05 ,pp. : 437-446

Oxford University Press

Access to resources Recommend Favorite

Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody

By Omidfar Kobra   Amjad Zanjani Fatemeh   Hagh Arghavan   Azizi Maedeh   Rasouli Seyed   Kashanian Susan  

Molecular Biology Reports, Vol. 40, Iss. 12, 2013-12 ,pp. : 6737-6745

Springer Publishing Company

Access to resources Recommend Favorite